about
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma.Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision MedicineDe novo compartment deconvolution and weight estimation of tumor samples using DECODERKeratin 17 identifies the most lethal molecular subtype of pancreatic cancer
P50
description
researcher
@en
wetenschapper
@nl
name
Richard A Moffitt
@en
Richard A Moffitt
@nl
type
label
Richard A Moffitt
@en
Richard A Moffitt
@nl
prefLabel
Richard A Moffitt
@en
Richard A Moffitt
@nl
P31
P496
0000-0003-2723-5902